ØSTLANDET PHARMA INVEST AS
Operating
Eie, selge og investere i apotek, aksjer og fast eiendom, samt andre
aktiviteter i naturlig sammenheng med dette.
Investeringer i apotek, aksjer og fast eiendom, samt andre aktiviteter
i naturlig sammenheng med dette.
Organization
- CEO
- PA
Per Asbridge1963
- Chairman of the board
- PA
Per Asbridge1963
- Years since formation
- 17 years
- since Jul 9, 2009
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100,000
- 1 share class
- Total number of shareholders
- 1
- person
- Belongs to group of
Financials
- Annual total result 2025
- -44,976
- NOK
- Total equity 2025
- 505,560
- NOK
Last update: Mar 23, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
PA 1963 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
PA 1963 | Chairman | 100 % directly |
JN 1973 | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
PA 1963 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Dec 3, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
PA 1963 | Ordinary shares | 100,000 | 100 % |
Shares owned by the ØSTLANDET PHARMA INVEST AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 100,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 0Operating profit 2025: NOK -44,976Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -44,976 | 55,939 | 297,266 | 0 |
Total assets | 505,560 | 550,536 | 494,666 | 179,517 |
Total liabilities | 0 | 0 | 69 | 69 |
Total equity | 505,560 | 550,536 | 494,597 | 179,448 |
P&L
| Year | 2025 | 2024 | 2023 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 44,976 | 119,713 | 2,734 | 0 |
Operating result | -44,976 | -119,713 | -2,734 | 0 |
Financial income/costs | 0 | 175,651 | 300,000 | 0 |
Profit before tax | -44,976 | 55,939 | 297,266 | 0 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -44,976 | 55,939 | 297,266 | 0 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2021 |
|---|---|---|---|---|
Total fixed assets | 112,500 | 112,500 | 112,500 | 112,500 |
Total current assets | 393,060 | 438,036 | 382,166 | 67,017 |
Total assets | 505,560 | 550,536 | 494,666 | 179,517 |
Short term debt | 0 | 0 | 69 | 69 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 0 | 0 | 69 | 69 |
Contributed capital | 112,500 | 112,500 | 112,500 | 112,500 |
Retained earnings | 393,060 | 438,036 | 382,097 | 66,948 |
Total equity | 505,560 | 550,536 | 494,597 | 179,448 |
Total equity and liabilities | 505,560 | 550,536 | 494,666 | 179,517 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises